Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Oral Mesalamine for Prevention of Immune-Related Colitis in Ipilimumab/Nivolumab Treated Patients
NCT05663775Phase 2Recruiting
- Sponsor
- American Health Staffing Group
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Salcrozine in immune-related colitis (IRC), diarrhea, sponsored by American Health Staffing Group. Started Aug 2024; status: recruiting.
02
Drugs
Salcrozine
03
Conditions
immune-related colitis (IRC)diarrhea
Beyond the preview
Go deeper on NCT05663775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05663775.